TARGETED DELIVERY OF NANOPARTICLE-ENCAPSULATED P110BETA-SPECIFIC INHIBITOR FOR PROSTATE CANCER INTERVENTION
$485,437FY2009Department of the ArmyDOD
University Of Kansas Medical Center Research Institute, Inc.
University Of Kansas Medical Center Research Institute, Inc.